GLP therapies are transforming metabolic care, but their full impact depends on how well we can monitor and understand patient outcomes beyond the prescription, said Neeraj Katare , Founder, Tracky
Some patients may notice minimal change, particularly if their diabetes is well-controlled and they are taking other glucose-lowering medications such as metformin
Association between the prognostic nutritional index and chronic microvascular complications in patients with type 2 diabetes mellitus
In turn, T cells produce inflammatory cytokines, such as IL-17 and IL-23, which exacerbate skin inflammation (206, 209)
Experts said trials in which GLP-1s are added to standard treatment in some cancer patients but not others are needed to establish clear anti-cancer benefits